The primary sex determination signal, the X chromosome-to-autosome (X/A) ratio, controls the choice of sexual identity in the Drosophila melanogaster embryo by regulating the activity of the early promoter of the Sex-lethal gene, Sxl-P e . This promoter is activated in females (2X/2A), while it remains off in males (1X/2A). Promoter activation in females is dependent upon X-linked numerator genes. One of these genes, sisterless-b (sis-b), corresponds to the scute (sc) locus of the achaete-scute complex, and it encodes a helix-loop-helix transcription factor. In the studies reported here we have used monoclonal antibodies to study the expression and functioning of the sc(sis-b) protein. Sc is first detected at nuclear cycle 6 to 7, well before Sxl-P e is first active. At this stage, the protein is in the cytoplasm, not the nucleus. Only after the formation of the syncytial blastoderm, at nuclear cycle 10 to 11, does a substantial fraction of the protein enter the nucleus, and this nuclear import closely coincides with the initial activation of Sxl-P e . Consistent with the idea that the dose of sc(sis-b) is critical for its function as an X-chromosome counting element, wild-type syncytial blastoderm embryos could be grouped into two classes based on the level of protein. Western blot (immunoblot) analysis demonstrates that this difference in protein level correlates directly with the activity state of the Sxl gene. Finally, we provide the first direct evidence that Sc forms heteromeric complexes in vivo in early embryos with the maternally derived helix-loop-helix protein Daughterless. This in vivo complex is likely to be critical for Sc function in Sxl-P e activation.
The choice of sexual identity in the fruit fly Drosophila melanogaster is determined by the X chromosome-to-autosome (X/A) ratio (1, 16, 20, 48, 49) . A ratio of 1 (2X/2A) signals the initiation of the female developmental pathway, while a ratio of 1/2 (1X/2A) signals male development. The system that measures the X/A ratio operates only transiently during early embryonic development, and it functions to set the activity state of the binary-switch gene Sex-lethal (Sxl) (17) . In 2X/2A animals, the X/A signaling system turns on the Sxl gene, while the gene is not activated in 1X/2A animals. In the on state, the Sxl gene directs female development by controlling several regulatory cascades that function in different aspects of somatic sexual development (14, 32, 41, 44, 50) . These regulatory cascades include the transformer-doublesex somatic sexual differentiation pathway and the dosage compensation pathway (2, 8, 44) . The Sxl gene also provides the mechanism for remembering the female determined state (15) . This is accomplished through an autoregulatory feedback loop in which the Sxl protein directs its own expression by promoting the female-specific splicing of primary transcripts produced from the Sxl late or maintenance promoter, Sxl-P m (3, 4, 36, 37) . Similarly, the male determined state is maintained by the default splicing machinery, which splices primary transcripts from Sxl-P m in the nonproductive, male mode. In 1X/2A embryos, in which the Sxl gene remains off, the different regulatory cascades operate in the default mode, leading to male development.
While the on-off regulation of the Sxl gene from early embryogenesis through to the adult stage is determined by the alternate splicing of Sxl transcripts from Sxl-P m , the initial choice of sexual identity is made at the level of transcription (38) . In 2X/2A embryos an early Sxl promoter, Sxl-P e , located in the first intron of the maintenance transcription unit, is activated shortly after nuclear migration. The mRNAs expressed from this promoter encode an embryonic form of the Sxl protein (7, 38) . This embryonic protein sets the autoregulatory feedback loop in motion by directing the female-specific splicing of the first transcripts produced from the late promoter Sxl-P m , which initially turns on just prior to cellularization. In 1X/2A animals the Sxl-P e promoter is not activated and in the absence of embryonic Sxl protein, the first transcripts from Sxl-P m are spliced in the default, or male, mode.
The Sxl early promoter, Sxl-P e , appears to be the direct target for the system that signals the X/A ratio. Genetic studies have identified several different components of this signaling system. The first component is the X-linked numerators, the genes sisterless-a (sis-a), sisterless-b (sis-b) (or scute [sc] ), runt, and sisterless-c (sis-c), which function to promote the choice of the female pathway (17, 18, 27-29, 45, 53, 54) . In 2X/2A animals loss-of-function mutations in these genes can block the activation of the Sxl gene, causing sex transformations and lethality. The defect in initiating the Sxl autoregulatory feedback loop has been shown to be due to a failure to properly activate Sxl-P e (38) . The second component of this signaling system is the genes which function as autosomal denominators, promoting the male pathway. Thus far, only one zygotic denominator, deadpan (dpn), has been identified (5, 58) . In 1X/2A animals, mutations in dpn can lead to sex transformations and lethality by initiating the Sxl autoregulatory feedback loop. This defect in the choice of sexual identity is due to the inappropriate activation of Sxl-P e in male embryos (30) . The third component of the signaling system is genes whose products are contributed by the mother during oogenesis. One of these, daughterless (da), is required for the choice of the female pathway and facilitates the activation of Sxl-P e in 2X/2A animals by the products of the X-linked numerator genes (11, 13, 21, 22, 24) . The other maternal gene is extramacrochaete (emc), and it appears to function much like the zygotic autosomal gene dpn in keeping Sxl off in 1X/2A animals (31, 55) .
Consistent with their roles in regulating the Sxl-P e promoter, molecular analysis of the different components of the X/A signaling system indicates that they resemble known transcription factors. Sis-a is a member of the bZIP family of transcription factors (29) , while runt is homologous to a proto-oncogene responsible for acute myeloid leukemia (25) . The four other components of the signaling system, Da, Emc, Sc, and Dpn, are all members of the helix-loop-helix (bHLH) family of proteins. This class of proteins can form both homo-and heteromeric complexes, and they function as transcriptional regulators. Moreover, their regulatory effects on transcription have been found to depend upon the type of heteromeric complex that is formed; some complexes function to activate transcription, while others either are unable to activate transcription or may actually block activation (6, 42, 43) . In addition to the involvement of these bHLH genes in sex determination, they also function at later points in development in neurogenesis (19, 35, (52) (53) (54) .
With the aim of learning more about how the X/A ratio signals the activation of Sxl-P e , we have initiated molecular studies on the product of the sc gene. Molecular and genetic experiments have shown that the sc gene corresponds to the proneural sc gene from the achaete-scute gene complex (AS-C) (9, 10, 57) . The AS-C consists of four different genes: achaete, scute, lethal of scute, and asense. All four encode bHLH proteins. They function in the establishment of neuroblast identity and are required during embryogenesis and later during the larval and pupal stages for proper neural development. In the work reported here we have used monoclonal antibodies to examine the time of appearance and subcellular distribution of Sc in the early pre-cellular blastoderm embryo. Consistent with the postulated function of sc as a numerator element in the X/A signaling system, it is expressed at different levels in male and female embryos just prior to the activation of Sxl-P e . In addition, we show that Sc forms a heteromeric complex with the bHLH da protein in vivo.
MATERIALS AND METHODS
Strains and culturing. Flies were grown on a standard medium (12) at 25ЊC unless otherwise indicated. All alleles, marker mutations, and balancers are described by Lindsley and Zimm (40) .
DNA techniques. Several sc (T4) gene fusions were constructed to provide antigen for the production and screening of antibodies. The following strategy was used to generate a stable malE-T4-lacZ␣ tripartite fusion gene product by using T4 cDNA sequences (57) . Plasmid pMALc (New England BioLabs) was first digested with EcoRI and SalI, Klenow fragment treated to create blunt ends, and then religated. This modification of pMALc placed the lacZ␣ fragment out of frame with respect to malE coding sequences. A 335-bp cDNA fragment of the T4 gene was isolated by digestion with the restriction enzymes SspI and XmnI. This fragment encodes the predicted internal amino acid residues 175 through 286 but does not include the bHLH motif. Insertion of this fragment in the correct orientation into the StuI site of the above-described modified pMALc vector placed the malE gene in frame with T4 codons, which in turn were in frame with the lacZ␣ sequences. Insertion of the T4 fragment in the opposite and incorrect orientation introduces a translation stop codon just 3 positions downstream of the malE-T4 fusion point. A glutathione S-transferase (GST)-based tripartite fusion analogous to malE-T4-lacZ␣ was assembled by switching the GST domain from vector pGEX2 (51) for malE sequences of the constructed fusion gene. A trpE-T4 fusion gene was assembled by ligation of an SspI-derived 808-bp T4 cDNA fragment into the blunt-ended BamHI site of expression vector pATH3 (39) . This T4 fragment encodes the C-terminal 171 residues of the Drosophila protein, including the region used in both tripartite fusions.
Generation of monoclonal antibodies. The malE-T4-lacZ␣ fusion gene product was purified from induced DH5␣ cultures by affinity chromatography according to the protocol of the manufacturer (New England BioLabs). Female BALB/c mice were injected intraperitoneally with 50 to 100 g of purified antigen in Freund's adjuvant. Following the second boost, mouse sera were collected and screened for the presence of T4-specific antibodies by using Escherichia coli whole-cell lysates of DH5␣ that were induced for the expression of a trpE-T4 fusion product. The selected mouse was given a final boost with the GST gene-T4-lacZ␣ antigen that had been purified from induced DH5␣ cultures according to the manufacturer's protocol. The spleen cells from this mouse were isolated 3 days after the final boost and fused to myeloma cells in the presence of polyethylene glycol (Boehringer Mannheim). Approximately 600 parental hybridoma lines were screened with purified GST gene-T4-lacZ␣ fusion protein by the rapid procedure described by Hawkes et al. (34) . A total of 88 potential positives were rescreened against both trpE and trpE-T4 antigens in Western blot (immunoblot) analyses using induced DH5␣ whole-cell lysates. Those parental hybridoma lines producing antibodies that specifically recognize the trpE-T4 fusion protein but not the trpE control antigen were selected for subcloning. Although supernatants from four different hybridoma lines were tested initially, line 5A10 was used for all experiments reported here.
Western blot analysis. Staged embryos were washed from food plates, dechorionated in 50% bleach, and washed again in phosphate-buffered saline (PBS) prior to total protein extraction. Protein extracts were prepared essentially as described by Driever and Nusslein-Volhard (26) . Embryos were frozen in liquid nitrogen and then removed for thawing and homogenization in 2ϫ protein loading buffer. After incubation for 10 min at 95ЊC, insoluble material was sedimented. Subsequently, 10 to 15 l was applied to each slot on a sodium dodecyl sulfate (SDS)-10% polyacrylamide gel. After electrophoresis, protein was transferred to nitrocellulose paper in Tris-glycine buffer for 2 h at constant 250 mA. To assess the amount of total protein loaded and transferred for each lane, the blot was stained with Ponceau S red. After blocking with 5% low-fat dry milk powder in PBS-0.1% Tween 20, the blot was incubated overnight with the first antibody (1:10 dilution of hybridoma supernatant in PBS-0.1% Tween 20 at 4ЊC). A horseradish peroxidase-conjugated anti-mouse antibody kit from Promega was used for subsequent detection of antigen-antibody complexes on the blot.
Immunolocalization in whole-mount embryos. Embryos were dechorionated for 2 to 3 min in 50% bleach, washed thoroughly in PBS, and incubated in heptane-saturated fixative (4% paraformaldehyde, Polysciences electron microscopy grade, in PBS) for 30 min at room temperature. The fixative phase was then removed and replaced with 90% methanol-10% 0.5 M ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA). After several vigorous shakes, the devitellinized embryos that sank to the bottom were collected and rinsed several times in the methanol-EGTA solution and then in plain methanol. For staining, embryos were gradually rehydrated in PBS and incubated with 1% bovine serum albumin (BSA)-1% Triton X-100 in PBS for 3 to 4 h at room temperature. The first antibody was applied as a 1:10 dilution of hybridoma supernatant in PBS-0.1% BSA-0.1% Triton X-100 and incubated overnight at 4ЊC. After several washes in the same buffer, embryos were treated with biotinylated secondary antibody for 2 h at room temperature and subsequently with biotinylated horseradish peroxidase-avidin complexes according to the Vecstastain protocol (Vector Laboratories). The bound complexes were visualized with an immunohistochemical detection kit from the same company. Photomicrographs were taken on Ektar 125 film (Kodak) with a Zeiss photomicroscope. For confocal microscopy, anti-mouse secondary antibody coupled to the fluorescent probe, rhodamine red, was used in place of the biotinylated secondary antibody. Nucleic acids were stained with YoPro dye (Molecular Probes). Samples were washed as described above and were mounted in Aquamount.
Immunoprecipitations. Immunoprecipitations were performed essentially as described previously (33) . Monoclonal antibodies against Da and Dpn proteins were obtained from Claire Cronmiller and Harold Vassein (5, 23) . In order to generate antibodies specific to Sc, the well-conserved bHLH domain and the very C-terminal region (diagonal lines) were excluded. As indicated in the schematic showing the malE-T4-lacZ␣ sandwich construct, antibodies were raised against the T4 peptide sequences extending from amino acid residues 175 through 286 (solid box). Monoclonal antibody-producing lines recognizing T4 peptide sequences were identified by using the fusion protein expressed from the trpE-T4 construct.
RESULTS
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the N-terminal half of the protein is a 60-amino-acid bHLH domain. This bHLH domain shows a high degree of sequence similarity to the bHLH domains found in the proteins encoded by the other AS-C genes lethal-of-scute (T3), achaete (T5), and asense (T8) and, to a lesser extent, to other members of the bHLH family of transcription factors (47, 57) . The C-terminal half of Sc, with the exception of the very C terminus (which has an amino acid sequence similar to those of the C termini of the lethal-of-scute [T3] and achaete [T5] proteins), appears to be unique. In order to obtain monoclonal antibodies which would specifically recognize Sc but not the other proteins from the AS-C, we used a part of the C-terminal domain that roughly corresponds to this unique region (amino acids 175 to 286) as an antigen. Fusion proteins containing only this truncated Cterminal domain were unstable, and a sandwich construct ( Fig.  1 ) was required to obtain sufficient quantities of the Sc antigen for immunization (see Materials and Methods). We then used a trpE-T4 fusion protein to monitor the immune response and identify potential monoclonal lines that express antibody directed against Sc. We recovered several lines that recognize the trpE-T4 fusion protein, and these were analyzed further with Western blots of proteins from embryo extracts. If the monoclonal antibodies recognize Sc in embryo extracts, we expect to observe a protein species of approximately 39 kDa in the Western blots. The other bHLH genes from the AS-C should produce proteins that are significantly larger or smaller than Sc. asense (T8) is expected to encode a larger protein of about 50 kDa, while lethal-of-scute (T3) and achaete (T5) are predicted to encode smaller proteins of 29 and 22 kDa, respectively. Hence, if our monoclonal antibodies also recognized any of the other members of the AS-C, it should be possible to resolve these proteins species from Sc. As illustrated by a Western blot with the monoclonal antibody line 5A-10 ( Fig. 2A , lane 1), we observed one very prominent band with an apparent molecular size of 42 kDa. This is very close to the predicted size of the protein encoded by the sc (T4) gene. We did not, however, observe bands corresponding to the sizes predicted for the other bHLH proteins from the AS-C. Similar results were obtained with other monoclonal lines; in each case we also observed only one prominent band of the size predicted for Sc. An identical blot was probed with secondary antibody alone. As shown in Fig Wild-type (WT) and sc 3-1 flies were reared at 22ЊC. Extracts were prepared from embryos collected between 0 and 2.5 h. Proteins were separated on an SDS-10% polyacrylamide gel, blotted onto a nitrocellulose membrane, and probed with Sc monoclonal antibodies or affinity-purified antiactin antibodies (control). Relative levels of Sc in sc 3-1 and wild-type lanes were determined by scanning the X-ray films of several different Western blots of mutant and wild-type extracts.
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To provide further evidence for the specificity of our Sc monoclonal antibodies, we used an sc mutant allele, sc , which is predicted to encode a truncated version of Sc. DNA sequence analysis of sc suggests that the mutation is due to a C-to-T transition at nucleotide 1147. This nucleotide change produces an in-frame translation stop codon after amino acid position 162 in the Sc sequence (57) . Since the translation of the sc protein is expected to stop after position 162, the protein produced by this mutant should lack the C-terminal segment (residues 175 to 286) that we used to generate the Sc monoclonal antibody. Protein extracts were prepared from sc 10-1 adult males and used in a Western blot. As expected, the sc 10-1 protein is not detected by the monoclonal antibody (5A-10), while it is present in wild-type males.
Temperature-dependent reduction in the level of Sc with the temperature-sensitive allele sc . To further test the specificity of the monoclonal antibodies we took advantage of the sc mutant allele sc . Previous studies by Parkhurst et al. (47) have shown that this mutation affects the regulation of the sc gene in early embryos, and the expression of sc transcripts in sc 3-1 appears to be delayed and is markedly reduced relative to that of the wild type. This delay and the reduction in the level of sc transcripts are associated with a temperature-sensitive defect in female sex determination that is due to a failure to properly activate Sxl-P e (29, 30) . The defects in Sxl-P e activity in sc 3-1 female embryos are evident even at permissive temperatures (18 and 22ЊC) and become more pronounced at nonpermissive temperatures (25 and 29ЊC) (30) . If our antibody specifically recognizes Sc, we should observe a reduction in the level of the 42-kDa protein species in Western blots of sc 3-1 embryos. Shown in Fig. 2C is a Western blot of extracts prepared from 0-to 3-h wild-type and sc embryos (grown at 22ЊC) probed with the Sc antibody or antibody directed against actin. As expected, we find that the level of Sc in sc 3-1 mutant embryos is reduced relative to that in the wild type. In other experiments (not shown) we have found that the level of Sc (relative to that of actin) in mutant embryos is further reduced at higher temperatures.
Developmental expression pattern of Sc. Previous Northern (RNA) analysis has shown that the sc transcripts begin to accumulate in very early (0-to 2-h) embryos. The level of sc mRNA continues to increase between 2 and 4 h and then remains constant through the first half of embryonic development. Message accumulation then appears to cease midway through embryogenesis, and sc RNA cannot be detected in 12-to 24-h embryos or in first-and second-instar larvae. sc mRNA reappears during disc development in third-instar larvae and pupae, while it cannot be detected in adults (29) .
As shown in Fig. 3 , the pattern of accumulation of Sc is somewhat different from that of the mRNA. In Western blots we can first detect Sc in 0-to 1-h embryo collections. In this context it is interesting to note that there is some disagreement regarding the earliest point of sc mRNA expression (29, 47) . Parkhurst et al. (47) have reported that sc transcripts can be detected as early as nuclear division cycle 3, while Erickson and Cline (29) found that expression was not evident until around nuclear cycle 9. Since most of the embryos in our 0-to 1-h collections are pre-nuclear-cycle 9, it seems likely that sc mRNA is first expressed somewhat earlier than the ninth cycle. This possibility is supported by results of whole-mount staining experiments presented below.
Only relatively low levels of Sc are evident in 0-to 1-h embryos. (Although it is low, we believe that the signal in early embryos is real and zygotically derived, as unfertilized eggs which are often found in 0-to 3-h embryo collections never show staining above background.) The level of protein increases in the interval between 1 and 3 h and reaches a maximum in 3-to 4-h embryos. This high level of protein appears to be sustained in the interval between 4 h and the end of embryogenesis at 24 h. By way of contrast, no mRNA is detected during the last 12 h of embryogenesis (29) . Moreover, though no sc mRNA is found in the first and second larval stages (29) , readily detectable levels of protein are observed. These findings suggest that Sc synthesized during the first 12 h of embryogenesis is stable for several days after the sc mRNA has apparently turned over and is no longer detectable. In third-instar larvae and in pupae the level of Sc increases, presumably as a consequence of the de novo mRNA accumulation observed in these stages (29) . Finally, though little or no sc mRNA is evident in adults, protein is readily detected. As was the case earlier in development, the protein found in adults is likely to be derived from the translation of sc mRNA during the third-instar larval or the pupal stage.
Df(1)sc19 embryos do not make Sc. To provide evidence for the specificity of our monoclonal antibodies in whole mounts, we examined the staining pattern in embryos lacking the sc   FIG. 3 . Developmental expression profile of Sc. Total protein extracts were prepared from flies at different developmental stages, separated on an SDS-10% polyacrylamide gel, and blotted onto a nitrocellulose membrane. The blot was probed with monoclonal antibodies raised against Sc. Antibodies to actin (0-to 24-h embryonic extract blot) and tubulin (L1 to adult) were used as loading controls. L1, first-instar larvae; L2, second-instar larvae; L3, third-instar larvae.
VOL. 15, 1995 sc FUNCTION IN SEX DETERMINATION  4433 gene. For this purpose we used a deficiency chromosome, Df(1)sc19, which deletes the sc, achaete, and lethal-of-scute genes of the AS-C. The X-linked deficiency Df(1)sc19 was balanced against the Binsinscy (Bins) chromosome, which carries a duplication of the AS-C. Three classes of embryos, which differ in their dose of sc, are expected to be produced from this Df(1)sc19; Bins stock. In the first class, which should comprise a quarter of the population, would be male embryos that carry the Df(1)sc19 chromosome and consequently lack the sc gene.
In the second class would be Bins male embryos and Df(1)sc19/ Bins female embryos that have two copies of sc. This class should represent one half of the population. Finally, the third class (the remaining quarter) would consist of Bins/Bins female embryos which have four copies of sc.
As anticipated, approximately one-fourth of the embryos showed little or no staining with the Sc monoclonal antibody, while staining was clearly evident in the remaining threefourths. Representative embryos at three different stages of development-nuclear cycle 10 (panels A and B), cellular blastoderm (panels C and D), and germ band extended (panels E and F)-are presented in Fig. 4 . As can be seen from comparing the negative and positive embryos at equivalent stages of development, little or no staining can be detected in the putative sc deletion mutant animals. The lack of cross-reacting material in approximately a quarter of the embryos (coupled with our Western analysis) argues that the antibodies produced by this monoclonal line specifically recognize Sc. Similar results were obtained with the other monoclonal antibodies and with another mutant chromosome, In(1)sc8Lsc4R, which lacks the sc gene.
Interestingly, among the positive embryos there appeared to be two classes: approximately two-thirds of the positive embryos showed moderate staining, while the remaining one-third showed more intense staining (data not shown). We presume that this reflects the fact that one-half of the total embryos should have two copies of sc while one-fourth should have four copies.
Monoclonal antibodies to Sc can detect differences in the levels of protein in early embryos. Sex determination in the Drosophila soma is dependent upon the relative gene dose of the zygotically active X-linked numerator elements and the maternal or zygotic denominators that function as autosomal counting elements (18, 54) . It is hypothesized that the twofold difference between male and female embryos in the copy number of numerator genes like sc translates directly into a twofold difference in the level of the corresponding gene product (18, 54) . This dose dependence in the level of X-linked gene expression would be unique to early embryogenesis and would reflect the fact that the dosage compensation system either is inoperative at this stage of development or functions in both sexes until it is turned off in females when the Sxl protein is first produced. In either case, a prediction of this model is that there should be two populations of early embryos, corresponding to 1X and 2X animals, which differ in the level of Sc.
To test this hypothesis we stained early white 1 embryo collections with our Sc monoclonal antibodies. Although we can detect differences in the level of Sc in pre-cycle 9 embryos (see also below), it is not possible to reliably classify them into two distinct groups on the basis of the intensity of antibody staining-some show stronger staining, some show weaker staining, but there is also a fairly large group of embryos which show intermediate levels of staining. The embryo population can, however, be readily divided into two groups after syncytial blastoderm formation when the amount of Sc has increased. The differences in the level of Sc staining between the two groups is illustrated by the two cycle 12 embryos shown in Fig. 5A . We analyzed 389 blastoderm embryos that were between cycles 11 and 13. To eliminate cycle-dependent differences in protein levels, these embryos were first grouped by nuclear density and were then scored for the relative intensity of Sc antibody staining. Of these syncytial blastoderm embryos, 189 showed dark staining while 200 stained more lightly, which is near the expected ratio of 1X to 2X animals. These findings suggest that the level of Sc is proportional to the gene dose during the syncytial blastoderm stage and perhaps even earlier. This corresponds closely to the time when the X/A ratio is thought to be measured and the Sxl gene first activated (7, 28) .
The presence of two groups of embryos which differ in the level of Sc seems to persist until the onset of gastrulation, at which point all of the similarly staged embryos begin to show essentially the same staining intensity and spatial distribution. Since the sc transcripts expressed in the initial burst disappear at the beginning of nuclear cycle 14 (29, 47 ), the differences in protein level evident during the early stages of gastrulation are likely to reflect the perdurance of Sc synthesized (in 1X and 2X animals) prior to cellularization. On the other hand, the equalization of protein levels in the slightly older embryos suggests that the dosage compensation system must be functioning in males and turned off in females at or before the time when the sc gene is reactivated and the proneural pattern of expression develops.
Weakly stained embryos are male, while female embryos stain more darkly. In the experiments described in the previous section we could divide the pre-cellular blastoderm embryos into two groups on the basis of the level of Sc antibody staining. Our interpretation of these results is that the group showing lighter staining corresponds to male embryos which have only single sc gene, while the group showing stronger staining corresponds to female embryos which have two sc genes. If this interpretation is correct, then the staining intensity of the embryos should be correlated with the activity of the regulatory target for Sc, the Sxl gene. The Sxl gene should be in the off state in the more lightly staining male embryos, while it should be in the on state in the more darkly staining female embryos.
To determine if this is the case, staged embryos (0 to 3 h) were stained with the Sc monoclonal antibody. We then grouped and separated the syncytial blastoderm-stage embryos (nuclear cycle 12 to 13) on the basis of their Sc antibody staining intensity (light versus dark). Extracts were prepared from 20 embryos in each group and analyzed by Western blotting using Sxl antibody (Fig. 5B) . To control for protein extraction or loading artifacts, we also probed the Western blots with antibody directed against lamin (Fig. 5B) . As predicted, we could not detect the Sxl protein in the group of Carefully staged whole-mount embryos (syncytial blastoderm) were stained with monoclonal antibodies to Sc. Shown are two embryos, one strongly stained and one more weakly stained (presumably female and male embryos, respectively). (B) Embryos 0 to 3 h old were stained with Sc monoclonal antibodies, and syncytial blastoderm embryos were grouped on the basis of intensity of staining (weak versus strong). Extracts were prepared from both classes of embryos, and proteins were separated by SDS-PAGE and were blotted onto nitrocellulose. Blots were analyzed for the Sxl protein with Sxl monoclonal antibodies. Lane 1, extract from embryos stained weakly with Sc antibody; lane 2, extract from embryos stained strongly with Sc antibody; lane 3, extract from adult males; lane 4, extract from adult female. The same blot was reprobed with antibody specific for lamin (loading control). To assess the sensitivity of our assay we did a reconstruction experiment in which extracts from lightly staining, ostensibly male embryos were doped with increasing amounts of extracts from darkly staining, ostensibly female embryos. In this experiment we were readily able to detect Sxl protein in male extracts doped with protein from the equivalent of two female embryos. (We did not try doping with extract equivalent to one female embryo.) Thus, of the 20 lightly stained embryos examined in lane 1, fewer than 2 of these express Sxl protein. Of course, this doping experiment does not control for mistakes in the opposite direction, namely, darkly stained embryos which do not express the Sxl protein.
VOL. 15, 1995 sc FUNCTION IN SEX DETERMINATION 4435 embryos that stained only lightly for the Sc antigen. In contrast, the Sxl protein was present in the group of embryos that stained more darkly for the Sc antigen. This result confirms the inferred sexual identity of the embryos in the lightly and more darkly staining groups and indicates that the level of Sc is correlated with the activity state of Sxl. Subcellular localization of Sc. Sc is a member of the bHLH family of transcription factors and consequently would be expected to predominantly nuclear. However, this did not seem to be the case from our immunohistochemical staining. As can be seen in Fig. 4B , much of the Sc in this nuclear cycle 9 embryo seems to be in the cytoplasm, not the nucleus (compare staining in the wild-type embryo in panel B with the sc deletion embryo in panel A) and the strong nuclear dots observed with other nuclear antigens at this stage (e.g., histones [data not shown]) is not evident. In older, pre-cellular blastoderm embryos, nuclear protein becomes evident. This is most clearly seen in the surface view of a immunohistochemically stained syncytial blastoderm embryo shown in Fig. 6A . However, even in this embryo substantial amounts of the protein also appear to be present in the cortical cytoplasm (Fig. 6B) .
To more precisely define both the time course of sc expression and the distribution of Sc during the early stages of embryogenesis, we used confocal microscopy. Since early embryos sometimes exhibit significant levels of nonspecific staining, we compared the staining pattern in wild-type embryos with that of Df(1)sc19 embryos of equivalent developmental age. The earliest stage at which Sc antigen could first reliably be detected in wild-type embryos is around nuclear cycle 6 to 7 (Fig.  6C ), though staining above background is often observed in even earlier embryos. These observations are consistent with the results of Parkhurst et al. (47) , who reported that sc transcripts are expressed as early as nuclear cycle 3. The staining at nuclear cycle 6 to 7 is considerably lighter than that observed for older embryos. Moreover, as illustrated by the panels showing Sc (Fig. 6C, F, I , and L), nucleic acids (Fig. 6D , G, J, and M), and the overlapping image (Fig. 6E, H, K, and N) , the Sc in these early embryos appears to be predominantly cytoplasmic, with little or no protein in nuclei.
The level of antibody staining increases substantially after the somatic nuclei migrate to the surface of the embryo. Moreover, by nuclear cycle 10 ( Fig. 6F to H) , Sc can be detected not only in the cytoplasm but also in the nuclei (as judged by the yellower nuclei in panel H than in panel E). The level of nuclear Sc appears to increase during cycles 11 to 13 ( Fig. 6I to  K) , which corresponds to the time in development when the Sxl-P e promoter is active. However, even during this critical period, a substantial proportion of the protein appears to remain in the cytoplasm. This partitioning of Sc into both the nuclear and cytoplasmic compartments during the syncytial blastoderm stage is illustrated in the higher magnification of a blastoderm embryo shown in Fig. 6L to N. While high levels of protein are found in the somatic nuclei and cytoplasm, the level of Sc in the nuclei or cytoplasm of the germ line pole cells is consistently much lower ( Fig. 6B and I to K). In this regard, it is interesting to note that Sxl-P e is activated in somatic nuclei but not in the pole cells. Presumably this may be due, at least in part, to soma-germ line differences in the level of Sc. During cellularization, there is a further redistribution of Sc into the nuclei, and in subsequent stages of embryogenesis it is preferentially localized in nuclei, not in the cytoplasm (data not shown). Protein-protein complexes are formed between Sc and Daughterless. The binding of bHLH proteins like Sc to DNA is believed to require the formation of protein-protein complexes, usually in the form of heterodimers (or hetero-oligomers) between two different bHLH proteins. In mammals, such heterodimers often consist of a tissue-or cell-type-specific bHLH protein complexed with a more ubiquitous protein. A very good candidate for the partner of Sc in sex determination (and also neurogenesis) is the ubiquitous bHLH protein encoded by the da gene. da protein derived from the mother is required in the early zygote for the activation of Sxl-P e (30, 37) , and it has been suggested that heteromeric complexes between the numerator element Sc and Da would interact with Sxl-P e to activate expression in female embryos (45) . Consistent with this suggestion, in vitro experiments have demonstrated that heteromeric complexes of Da and the various bHLH proteins encoded by the AS-C can be assembled on DNA oligomers containing bHLH E-box consensus binding sites (9, 55) .
Balancing the positive effects of Sc-Da complexes would be complexes formed with negative regulatory proteins encoded by denominator elements on the autosomes. Evidence for such negative regulatory interactions comes from previous studies by Parkhurst et al. (45) , who showed that ectopic expression of the bHLH protein Hairy from a hunchback (hb) promoter blocked the activation of Sxl, leading to female-specific lethality. Moreover, duplication of sc, but not da, suppresses the female lethality of the hb:h transgene. These findings led to a model in which the bHLH protein Hairy binds to Sc, competing with the formation of Sc-Da complexes and hence preventing Sxl-P e activation (45) . Since the endogenous hairy gene is not normally expressed until after Sxl-P e is activated (and turned off), it was postulated that some other bHLH protein encoded by an autosomal denominator gene would compete with Da for complex formation with Sc. One candidate for such a denominator element is the autosomal bHLH gene deadpan (58) . Mutations in dpn lead to the inappropriate activation of Sxl-P e in males (30) and cause male lethality.
This model for the regulation of Sxl-P e by the X/A signaling system predicts the formation of two types of Sc complexes in vivo-positive regulatory complexes between Sc and Da and negative regulatory complexes between Sc and Dpn. To test the first part of this model, we determined whether heteromeric complexes between Sc and the da protein can be detected in early embryos. For this purpose extracts from 0-to 3-h embryos were immunoprecipitated with antibodies directed against either Da or Sc and protein A-Sepharose beads. The embryonic proteins immunoprecipitated by antibody attached to the Sepharose beads were then analyzed by Western blotting.
In the Western blot shown in the first panel of 6 and 7, respectively) . To test the second part of this model, we attempted to detect complexes between Sc and Dpn by immunoprecipitation. In contrast to Sc-Da, we were unable to detect Sc-Dpn complexes.
With the very important caveat that these are negative findings, it appears that Sc and Dpn do not form complexes in vivo.
DISCUSSION
The selection of the male or female developmental pathway depends upon a signaling system that controls the transcriptional activity of the Sxl-P e promoter. The activity of this signaling system is thought to pivot upon the twofold difference between 1X and 2X embryos in the gene dose of X-linked numerators that encode a number of different transcription factors such as the bHLH protein Sc; that is, one copy of the numerators is insufficient to activate Sxl-P e , while the promoter is activated when two copies of the numerators are present. It is believed that this twofold difference in X-chromosome gene dose is amplified by the formation of concentration-dependent protein-protein interactions between these positive transcription factors and other components of the signaling system such as the maternal gene da (20, (45) (46) (47) . Countering the effects of the transcription factors encoded by genes on the X chromosome are factors which function as denominators and act to keep Sxl-P e off. Some of these are thought to form inhibitory protein-protein complexes with numerator proteins, while others may interact directly with Sxl-P e (20, 30, 45, 58) . In the studies reported here we have sought to test certain aspects of this model for sex determination by undertaking a detailed in vivo analysis of the protein encoded by the numerator gene sc. Our results with sc are consistent with many but not all of the major predictions of this model and also suggest that some of the mechanisms involved are more complicated than initially imagined.
The level of Sc is dependent upon X-chromosome gene dose. One key feature of the model is that in the early zygote, at the time when the X/A ratio is being read, the level of expression of X-linked numerator proteins is directly dependent upon gene dose. Several lines of evidence suggest that this is the case for sc. We find that wild-type embryos at the syncytial blastoderm stage-the stage at which Sxl-P e is activated-can be divided into two groups on the basis of the intensity of Sc antibody staining. One group of embryos stains lightly, while the other stains more darkly. As would be expected if the level of staining depends upon the number of X chromosomes, a roughly equal number of embryos partition into each group. That this difference in staining intensity reflects the sc gene dose per se and is not the consequence of some other sexspecific difference that occurs independently of the number of sc genes is supported by analysis of the Sc staining pattern observed in a genetic background in which embryos have zero, two, or four copies of sc. In this case, the sc-positive embryos fall into two groups at the frequency expected from the genetic background, not the sex. The fact that the level of Sc appears to depend strictly on gene dose argues that the dosage compensation system must not be functioning (or must be active in both sexes) during the syncytial blastoderm stage. Of course, this is not the case later in development. By the time the neurogenic pattern of sc expression develops in a wild-type genetic background, all embryos (1X and 2X) show essentially the same level of staining. Finally, we show that the level of Sc in wild-type pre-cellular blastoderm embryos is directly correlated with their sexual identity. This is demonstrated by the finding that the Sxl gene is not turned on in embryos that show light staining with Sc antibody but is on in the more darkly stained embryos.
While these findings support one key prediction of the model, our studies reveal other factors that must ultimately be of some importance in establishing the effective dose of Sc. One of these is the subcellular distribution of the protein. Even though Sc can be detected in the nuclear division cycles prior to the formation of the syncytial blastoderm, very little of this protein is nuclear. Even after nuclear migration (nuclear cycles 9 and 10), much of the protein remains in the cytoplasm, and it is only around nuclear cycle 11 or 12 that a significant amount begins to enter the nucleus. This coincides closely to the time when Sxl-P e is initially activated (29, 38) . This raises the possibility that nuclear import of Sc is an important factor in controlling when the promoter can first be turned on. Whether nuclear import has an impact not only on timing but also on sex specificity is less clear. There does not appear to be any sex specificity in nuclear import, and all of the similarly staged embryos (whether in the darkly or lightly staining classes) show an equivalent distribution of cytoplasmic and nuclear protein. On the other hand, it is possible that the delayed nuclear import plays an indirect role in ensuring the appropriate sex specificity of the promoter. Thus, if nuclear import began earlier, the effective concentration of Sc in 1X nuclei might ultimately exceed the threshold required for activating the promoter. In this respect, it is interesting to note that much of the Sc is still in the cytoplasm even during the peak period of Sxl-P e activity. Were all of this cytoplasmic protein localized in the nucleus, the level of nuclear Sc in 1X animals might exceed that required to begin activating Sxl-P e in these embryos (29, 30) .
Curiously, incomplete nuclear import of Sc evident at the syncytial blastoderm stage is not observed at later stages of development in which the protein appears to be predominantly nuclear (56) . This raises the possibility that the import machinery for Sc is limiting in early embryos. Alternatively, it is possible that different nuclear localization signals (and perhaps somewhat different machinery) are employed early and late. In either case, one might anticipate that at least some loss-offunction mutations in the sc gene that are specific for sex determination (but do not affect neurogenesis) lie in the signal sequence used for early nuclear import.
Regulation mediated by protein dimer formation. A second feature of the model is that concentration-dependent proteinprotein interactions may help to amplify the twofold difference between males and females in the dose of X-linked numerator genes. Among the known components of the X/A signaling system, the bHLH proteins encoded by sc, da, dpn, and emc are very good candidates for proteins whose activity may be modulated by the formation of dimeric or multimeric complexes. Indeed, previous in vitro studies have shown that Da can form heteromeric complexes with Sc and other bHLH proteins from the AS-C on DNA oligomers containing consensus binding sequences (9, 55) . Moreover, in vitro-synthesized da protein was found to form heteromers with the AS-C proteins Lethalof-scute, Achaete, and Sc in the absence of DNA; however, the stability of the Da-Sc complex appeared to be much less than that of complexes formed between Da and either Lethal-ofscute or Achaete (9) . Since bHLH proteins can be somewhat promiscuous in their interactions, an obvious question is whether the complexes observed in vitro between Da and Sc can also be detected in vivo. This is especially important to establish given the marginal stability of the in vitro complexes. To assay for complexes between Da and Sc in vivo, we have used reciprocal coimmunoprecipitations of proteins extracted from early embryos. We have shown that Sc antibodies coimmunoprecipitate Da from early embryo extracts, while Da antibodies coimmunoprecipitate Sc. These results provide the first direct evidence for the existence of Da-Sc complexes in vivo.
A number of studies indicate that Sc is limiting, while the da protein is normally present in excess. Hence, the formation of complexes between Sc and Da would be expected to depend most critically upon the relative concentration of Sc. In this case the differences in the level of Sc observed in 1X and 2X animals could have a significant effect on the number of such complexes that are formed in each sex. Perhaps also important in this equation is the fact that a substantial fraction of the Sc is partitioned into the cytoplasm rather than the nucleus. By contrast, Da is reported to be predominantly nuclear in the early embryo, with little protein in the cytoplasm (23) . This difference in subcellular distribution would reduce the amount of Sc available to form functional complexes inside the nucleus. It could help amplify the effects of the twofold difference in the level of Sc between males and females, perhaps via denominators whose effects could be enhanced at lower effective numerator concentrations.
In many of the current models for measuring the X/A ratio (20, 29, 45) it is supposed that another mechanism for signal amplification involves negative interactions between numerator and denominator proteins. In the case of Sc, the formation of active complexes with Da is thought to be in direct competition with the formation of inactive complexes between Sc and bHLH proteins which function to convey the autosomal signal. One of the candidates for such inhibitory bHLH proteins is the autosomal gene dpn. In our experiments we were unable to detect a complex between Sc and Dpn. Although it must be emphasized that this is a negative result, it raises the possibility that Dpn functions by some other mechanism, i.e., interacting directly with targets in the Sxl-P e promoter and repressing transcription. Such a mechanism would be consistent with results obtained in functional studies with the promoter (30). Another possible inhibitory protein which was not tested here is the maternally expressed bHLH gene emc. This protein has been shown to interfere in vitro with the DNA binding of Da-Sc complexes (55) , and it could prevent these interactions by forming inactive protein-protein complexes with either Da or Sc. Further studies will be required to address this possibility.
